Launch Special: 25% Off EVERYTHING! Use Code LAUNCH25 at Checkout!
Need help? Call Or Text us, and a team member will be happy to assist you. +1-786-957-0245
Need help? Call Or Text us, and a team member will be happy to assist you. +1-786-957-0245
Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) under investigation for its interactions with pituitary signaling pathways and somatotropic axis regulation. Research studies are examining its biochemical effects on lipid metabolism, adipose tissue dynamics, and neuroendocrine mechanisms. Scientists continue to explore its role in metabolic pathway modulation and growth hormone secretion processes. This material is for research purposes only and is not intended for human use.
Price range: $110.00 through $175.00
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has been investigated for its effects on body composition. Its mechanism of action involves stimulating the pituitary gland to produce and release endogenous growth hormone. This, in turn, can lead to a reduction in visceral adipose tissue (VAT), the fat that surrounds the internal organs.
Key research areas for Tesamorelin have focused on its use in individuals with HIV-associated lipodystrophy, a condition characterized by excess abdominal fat. Clinical trials have demonstrated that Tesamorelin can significantly reduce VAT in this population. Further research is exploring its potential applications in other conditions, such as non-alcoholic fatty liver disease (NAFLD) and peripheral nerve injuries.
For research purposes only. This product is not intended to diagnose, treat, cure, or prevent any disease.
CAS: 218949-48-5
PubChem CID: 16137828
Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight: 5135.86 g/mol
Amino Acid Sequence: Modified 44-amino acid GHRH analogue with trans-3-hexenoic acid modification
Physical Form: Lyophilized Powder
Purity: ≥99%
Storage: -20°C, protected from light and moisture
